| Clinical data | |
|---|---|
| Other names | 3-Methoxy-8-aza-19-norpregna-1,3,5(10)-trien-20-yn-17-ol; W-4454A |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C20H25NO2 |
| Molar mass | 311.425 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Estrazinol (INN; also known asestrazinol hydrobromide (USAN),3-methoxy-8-aza-19-norpregna-1,3,5(10)-trien-20-yn-17-ol, or development codeW-4454A) is asynthetic,steroidalestrogen that was synthesized in 1968 and further characterized in 1973 but was never marketed.[1] It is described as awater-soluble estrogen.[2]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |